SciELO - Scientific Electronic Library Online

 
vol.40 número1Valoración de las regiones organizadoras nucleares en lesiones melánicas benignas y malignas de pielEstudio clínico de pacientes con neuropatía mielo-óptica índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista Cubana de Medicina

versão impressa ISSN 0034-7523versão On-line ISSN 1561-302X

Resumo

NENINGER VINAGERAS, Elia; VELBES MARQUETTI, Pedro  e  DEL CASTILLO CARRILLO, Concepción. Incidencia de infección por el virus de la hepatitis B y C. Rev cubana med [online]. 2001, vol.40, n.1, pp.24-29. ISSN 0034-7523.

It is known that patients with malignant tumors, treated with cytostatics, are more exposed to viral infections because of the frequent use of the parenteral route of administration. This study analyzes the frequency of hepatitis B and C in patients under treatment. Three hundred and thirty six patients with different tumor locations were studied to analyze the serologic and clinical characteristics of the infested. The viral infection was screened through serologic markers Umelissa HbsAg and HVC. Blood values of alaninoaminotransferase, aspartate aminotransferase and bilirubine. A transcutaneous hepatic biopsy was taken. It was found that 3.27 % of patients caught infection, with predominance of hepatitis B virus infection. It was known that all the patients had been surgically treated and that drug therapy lasted from 4 to 15 months. The main risk factors found were surgeries, frequent parenteral access and blood transfusions. The most evident clinical sign was hepatomegalia. The results reveal a low incidence of B and C viral infection. The importance of carrying out the screening of B and C virus in patients under drug therapy, who present with high levels of hepatic enzymes

Palavras-chave : HEPATITIS B VIRUS; HEPATITIS C-LIKE VIRUSES; HEPATITIS B [diagnosis]; HEPATITIS C [diagnosis]; RISK FACTORS; BLOOD TRANSFUSION [adverse effects]; ANTINEOPLASTIC AGENTS [adverse effects]; INFECTIONS, INTRAVENOUS [adverse effects]; NEOPLASMS [drug therapy]; SEROLOGIC TESTS.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons